Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nocent-Ejnaini

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Revue Des Maladies Respiratoires|July 9, 2010
[Are there specific characteristics of COPD in women?]C Raherison, E Biron, C Nocent-Ejnaini, et al.
Revue Des Maladies Respiratoires|February 15, 2020
[Woman's asthma throughout life: Towards a personalized management?]C Raherison, A Hamzaoui, C Nocent-Ejnaini, et al.
Revue Des Maladies Respiratoires|August 11, 2005
[Development of a questionnaire concerning the knowledge of COPD]L Nguyen, C Raherison, M Lheureux, et al.
Revue Des Maladies Respiratoires|October 15, 2021
[Severe adult asthma and treatment adherence: Results of the FASE-CPHG study]C Maurer, C Raherison-Semjen, B Lemaire, et al.
Revue Des Maladies Respiratoires|April 12, 2020
[Physical activity in severe asthma: Results of the FASE-CPHG Study]D Coëtmeur, É Parrat, C Nocent-Ejnaini, et al.
Lung Cancer (Amsterdam, Netherlands)|May 17, 2011
Multicenter observational study of erlotinib therapy (OBSTAR) for non small-cell lung cancer: a GFPC studyA Vergnenègre, I Monnet, C Chouaïd, et al.
Revue Des Maladies Respiratoires|April 4, 2021
D Coëtmeur, É Parrat, C Nocent-Ejnaini, et al.
Respiratory Medicine and Research|December 16, 2020
The determinants of dyspnoea evaluated by the mMRC scale: The French Palomb cohortE H Ouaalaya, L Falque, J M Dupis, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Revue Des Maladies Respiratoires|July 9, 2010
[Are there specific characteristics of COPD in women?]C Raherison, E Biron, C Nocent-Ejnaini, et al.
Revue Des Maladies Respiratoires|February 15, 2020
[Woman's asthma throughout life: Towards a personalized management?]C Raherison, A Hamzaoui, C Nocent-Ejnaini, et al.
Revue Des Maladies Respiratoires|August 11, 2005
[Development of a questionnaire concerning the knowledge of COPD]L Nguyen, C Raherison, M Lheureux, et al.
Revue Des Maladies Respiratoires|October 15, 2021
[Severe adult asthma and treatment adherence: Results of the FASE-CPHG study]C Maurer, C Raherison-Semjen, B Lemaire, et al.
Revue Des Maladies Respiratoires|April 12, 2020
[Physical activity in severe asthma: Results of the FASE-CPHG Study]D Coëtmeur, É Parrat, C Nocent-Ejnaini, et al.
Lung Cancer (Amsterdam, Netherlands)|May 17, 2011
Multicenter observational study of erlotinib therapy (OBSTAR) for non small-cell lung cancer: a GFPC studyA Vergnenègre, I Monnet, C Chouaïd, et al.
Revue Des Maladies Respiratoires|April 4, 2021
D Coëtmeur, É Parrat, C Nocent-Ejnaini, et al.
Respiratory Medicine and Research|December 16, 2020
The determinants of dyspnoea evaluated by the mMRC scale: The French Palomb cohortE H Ouaalaya, L Falque, J M Dupis, et al.
Pageof 1